About OJO | Search | Ahead of print | Current Issue | Archives | Author Instructions | Reviewer Guidelines | Online submissionLogin 
Oman Journal of Ophthalmology Oman Journal of Ophthalmology
  Editorial Board | Subscribe | Advertise | Contact
https://www.omanophthalmicsociety.org/ Users Online: 499  Wide layoutNarrow layoutFull screen layout Home Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review
E. Poku,J. Rathbone,R. Wong,E. Everson-Hock,M. Essat,A. Pandor,A. Wailoo
BMJ Open.2014;4(7)e005244
2Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion
Szabolcs Balla,Eszter Zold,Laszlo Potor,Balazs Lukucz,Attila Vajas,Bernadett Ujhelyi,Valeria Nagy
European Journal of Ophthalmology.2021;31(5)2528
3A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study
Qader Motarjemizadeh,Naser Samadi Aidenloo,Siamak Sepehri
International Ophthalmology.2016;36(1)63

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal